C/EBPβ (CEBPB) protein binding to the C/EBP|CRE DNA 8-mer TTGC|GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 6, 2015, Pages 583-589

  Sayeed, Syed Khund ^a   Zhao, Jianfei ^a   Sathyanarayana, Bangalore K ^a   Golla, Jaya Prakash ^a   Vinson, Charles ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

5mC, 5hmC, 5fC, 5caC, carboxylation; Basic leucine zipper; C EBP|CRE motif; C EBP homodimer; CG dinucleotide; DNA binding

Indexed keywords

5 CARBOXYLCYTOSINE; 5 FORMYLCYTOSINE; 5 HYDROXYMETHYLCYTOSINE; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; DINUCLEOTIDE; SINGLE STRANDED DNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; CEBPA PROTEIN, MOUSE; CEBPB PROTEIN, MOUSE; CYTOSINE; CYTOSINE NUCLEOTIDES; DNA; DNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

ARTICLE; CIRCULAR DICHROISM; DENATURATION; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; THERMOSTABILITY; ANALOGS AND DERIVATIVES; ANIMALS; CHEMISTRY; CRYSTALLOGRAPHY, X-RAY; DNA METHYLATION; EMBRYONIC DEVELOPMENT; GENETICS; METABOLISM; NUCLEOTIDE MOTIFS;

MAMMALIA;

5-METHYLCYTOSINE; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; CRYSTALLOGRAPHY, X-RAY; CYTOSINE; CYTOSINE NUCLEOTIDES; DNA; DNA METHYLATION; DNA-BINDING PROTEINS; EMBRYONIC DEVELOPMENT; NUCLEOTIDE MOTIFS; TRANSCRIPTION FACTORS;

EID: 84930225469     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2015.03.002     Document Type: Article

References (57)

1. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25:1010-1022.
2. Iyer L.M., Tahiliani M., Rao A., Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009, 8:1698-1710.
3. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
4. Cadet J., Wagner J.R. TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014, 764-765:18-35.
5. Dawlaty M.M., Ganz K., Powell B.E., Hu Y.C., Markoulaki S., Cheng A.W., Gao Q., Kim J., Choi S.W., Page D.C., Jaenisch R. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 2011, 9:166-175.
6. Pastor W.A., Aravind L., Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 2013, 14:341-356.
7. Zhu S., Yoon K., Sterneck E., Johnson P.F., Smart R.C. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:207-212.
8. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
9. Liu Y., Nonnemacher M.R., Wigdahl B. CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection. Future Microbiol 2009, 4:299-321.
10. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
11. Rozenberg J.M., Shlyakhtenko A., Glass K., Rishi V., Myakishev M.V., FitzGerald P.C., Vinson C. All and only CpG containing sequences are enriched in promoters abundantly bound by RNA polymerase II in multiple tissues. BMC Genomics 2008, 9:67.
12. Iguchi-Ariga S.M., Schaffner W. CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation. Genes Dev. 1989, 3:612-619.
13. Tate P.H., Bird A.P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr. Opin. Genet. Dev. 1993, 3:226-231.
14. Hu S., Wan J., Su Y., Song Q., Zeng Y., Nguyen H.N., Shin J., Cox E., Rho H.S., Woodard C., Xia S., Liu S., Lyu H., Ming G.L., Wade H., Song H., Qian J., Zhu H. DNA methylation presents distinct binding sites for human transcription factors. Elife 2013, 2:e00726.
15. Quenneville S., Verde G., Corsinotti A., Kapopoulou A., Jakobsson J., Offner S., Baglivo I., Pedone P.V., Grimaldi G., Riccio A., Trono D. In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol. Cell 2011, 44:361-372.
16. Rishi V., Bhattacharya P., Chatterjee R., Rozenberg J., Zhao J., Glass K., Fitzgerald P., Vinson C. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20311-20316.
17. Flower K., Thomas D., Heather J., Ramasubramanyan S., Jones S., Sinclair A.J. Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor. PLoS ONE 2011, 6:e25922.
18. Vinson C., Chatterjee R. CG methylation. Epigenomics 2012, 4:655-663.
19. Gustems M., Woellmer A., Rothbauer U., Eck S.H., Wieland T., Lutter D., Hammerschmidt W. c-Jun/c-Fos heterodimers regulate cellular genes via a newly identified class of methylated DNA sequence motifs. Nucleic Acids Res. 2014, 42:3059-3072.
20. Buck M., Poli V., Hunter T., Chojkier M. C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol. Cell 2001, 8:807-816.
21. Darlington G.J., Ross S.E., MacDougald O.A. The role of C/EBP genes in adipocyte differentiation. J. Biol. Chem. 1998, 273:30057-30060.
22. Smink J.J., Leutz A. Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases. J. Mol. Med. (Berl.) 2010, 88:227-233.
23. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 1997, 16:7432-7443.
24. Mann I.K., Chatterjee R., Zhao J., He X., Weirauch M.T., Hughes T.R., Vinson C. CG methylated microarrays identify a novel methylated sequence bound by the CEBPB|ATF4 heterodimer that is active in vivo. Genome Res. 2013, 23:988-997.
25. Golla J.P., Zhao J., Mann I.K., Sayeed S.K., Mandal A., Rose R.B., Vinson C. Carboxylation of cytosine (5caC) in the CG dinucleotide in the E-box motif (CGCAG|GTG) increases binding of the Tcf3|Ascl1 helix-loop-helix heterodimer 10-fold. Biochem. Biophys. Res. Commun. 2014, 449:248-255.
26. Chatterjee R., Vinson C. CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression. Biochim. Biophys. Acta 2012, 1819:763-770.
27. Spruijt C.G., Gnerlich F., Smits A.H., Pfaffeneder T., Jansen P.W., Bauer C., Munzel M., Wagner M., Muller M., Khan F., Eberl H.C., Mensinga A., Brinkman A.B., Lephikov K., Muller U., Walter J., Boelens R., van Ingen H., Leonhardt H., Carell T., Vermeulen M. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013, 152:1146-1159.
28. Lercher L., McDonough M.A., El-Sagheer A.H., Thalhammer A., Kriaucionis S., Brown T., Schofield C.J. Structural insights into how 5-hydroxymethylation influences transcription factor binding. Chem. Commun. (Camb.) 2014, 50:1794-1796.
29. Johnson P.F. Identification of C/EBP basic region residues involved in DNA sequence recognition and half-site spacing preference. Mol. Cell. Biol. 1993, 13:6919-6930.
30. D.I. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
31. Vinson C.R., Hai T., Boyd S.M. Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. Genes Dev. 1993, 7:1047-1058.
32. Vallejo M., Ron D., Miller C.P., Habener J.F. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:4679-4683.
33. FitzGerald P.C., Shlyakhtenko A., Mir A.A., Vinson C. Clustering of DNA sequences in human promoters. Genome Res. 2004, 14:1562-1574.
34. Hata K., Nishimura R., Ueda M., Ikeda F., Matsubara T., Ichida F., Hisada K., Nokubi T., Yamaguchi A., Yoneda T. A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol. Cell. Biol. 2005, 25:1971-1979.
35. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 2007, 17:318-324.
36. Hirata M., Kugimiya F., Fukai A., Ohba S., Kawamura N., Ogasawara T., Kawasaki Y., Saito T., Yano F., Ikeda T., Nakamura K., Chung U.I., Kawaguchi H. C/EBPbeta promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57. PLoS ONE 2009, 4:e4543.
37. Stoilova B., Kowenz-Leutz E., Scheller M., Leutz A. Lymphoid to myeloid cell trans-differentiation is determined by C/EBPbeta structure and post-translational modifications. PLoS ONE 2013, 8:e65169.
38. Tsagaratou A., Aijo T., Lio C.W., Yue X., Huang Y., Jacobsen S.E., Lahdesmaki H., Rao A. Dissecting the dynamic changes of 5-hydroxymethylcytosine in T-cell development and differentiation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(32):E3306-15.
39. Hackett J.A., Dietmann S., Murakami K., Down T.A., Leitch H.G., Surani M.A. Synergistic mechanisms of DNA demethylation during transition to ground-state pluripotency. Stem Cell Rep. 2013, 1:518-531.
40. Pfeifer G.P., Xiong W., Hahn M.A., Jin S.G. The role of 5-hydroxymethylcytosine in human cancer. Cell Tissue Res. 2014, 356:631-641.
41. Rishi V., Potter T., Laudeman J., Reinhart R., Silvers T., Selby M., Stevenson T., Krosky P., Stephen A.G., Acharya A., Moll J., Oh W.J., Scudiero D., Shoemaker R.H., Vinson C. A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Anal. Biochem. 2005, 340:259-271.
42. Krylov D., Mikhailenko I., Vinson C. A thermodynamic scale for leucine zipper stability and dimerization specificity: e and g interhelical interactions. EMBO J. 1994, 13:2849-2861.
43. Vinson C., Myakishev M., Acharya A., Mir A.A., Moll J.R., Bonovich M. Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 2002, 22:6321-6335.
44. Vinson C.R., LaMarco K.L., Johnson P.F., Landschulz W.H., McKnight S.L. In situ detection of sequence-specific DNA binding activity specified by a recombinant bacteriophage. Genes Dev. 1988, 2:801-806.
45. Shuman J.D., Vinson C.R., McKnight S.L. Evidence of changes in protease sensitivity and subunit exchange rate on DNA binding by C/EBP. Science 1990, 249:771-774.
46. Wang S., Long Y., Wang J., Ge Y., Guo P., Liu Y., Tian T., Zhou X. Systematic investigations of different cytosine modifications on CpG dinucleotide sequences: the effects on the B-Z transition. J. Am. Chem. Soc. 2013, 136:56-59.
47. Robertson J., Robertson A.B., Klungland A. The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. Biochem. Biophys. Res. Commun. 2011, 411:40-43.
48. Choi I., Kim R., Lim H.W., Kaestner K.H., Won K.J. 5-hydroxymethylcytosine represses the activity of enhancers in embryonic stem cells: a new epigenetic signature for gene regulation. BMC Genomics 2014, 15:670.
49. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
50. Raiber E.A., Murat P., Chirgadze D.Y., Beraldi D., Luisi B.F., Balasubramanian S. 5-Formylcytosine alters the structure of the DNA double helix. Nat. Struct. Mol. Biol. 2015, 22:44-49.
51. Iurlaro M., Ficz G., Oxley D., Raiber E.A., Bachman M., Booth M.J., Andrews S., Balasubramanian S., Reik W. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 2013, 14:R119.
52. Song C.X., Szulwach K.E., Dai Q., Fu Y., Mao S.Q., Lin L., Street C., Li Y., Poidevin M., Wu H., Gao J., Liu P., Li L., Xu G.L., Jin P., He C. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 2013, 153:678-691.
53. Cadet J., Wagner J.R. TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014, 764-765:18-35.
54. Shen L., Wu H., Diep D., Yamaguchi S., D'Alessio A.C., Fung H.L., Zhang K., Zhang Y. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 2013, 153:692-706.
55. Gu T.P., Guo F., Yang H., Wu H.P., Xu G.F., Liu W., Xie Z.G., Shi L., He X., Jin S.G., Iqbal K., Shi Y.G., Deng Z., Szabo P.E., Pfeifer G.P., Li J., Xu G.L. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 2011, 477:606-610.
56. Di Stefano B., Sardina J.L., van Oevelen C., Collombet S., Kallin E.M., Vicent G.P., Lu J., Thieffry D., Beato M., Graf T. C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells. Nature 2014, 506:235-239.
57. Yu M., Hon G.C., Szulwach K.E., Song C.X., Zhang L., Kim A., Li X., Dai Q., Shen Y., Park B., Min J.H., Jin P., Ren B., He C. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012, 149:1368-1380.